Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30573815.
- Also identified by DOI 10.1038/s41592-018-0260-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present DeepNovo-DIA, a de novo peptide-sequencing method for data-independent acquisition (DIA) mass spectrometry data. We use neural networks to capture precursor and fragment ions across m/z, retention-time, and intensity dimensions. They are then further integrated with peptide sequence patterns to address the problem of highly multiplexed spectra. DIA coupled with de novo sequencing allowed us to identify novel peptides in human antibodies and antigens.
Medical subject headings
- Deep Learning
- Mass Spectrometry
- Peptides